Welcome to ESWI's Education Hub. Use the different filters or search button to find your preferred content. Video | ESWI webinar series 2021 Vaccination in a COVID-19 era First webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Sylvie ... Video Partner Organisations | 7th Influenza Conference 2020 Should we introduce national live vaccination programmes for children? ESPID/ESWI joint symposium supported by AZ Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Current page 9 Search Search Keywords Title Topic - Any -Animal InfluenzaAvian InfluenzaH5N1Viral TimesAntibodiesAntivirals Antivirals and monoclonal antibodiesCommunicationCOVID-19COVID-19 PandemicDiabetesDiagnosticsEpidemiologyHPAIImmunologyInfluenzaInfluenza Diabetes CommunityLong-CovidLow and Middle Income CountriesmRNAOne HealthPandemic preparednessPandemic threatsPathogenesisPolicyPreventionPublic Health CareRSVSARS-CoV-2SARS-CoV-2 variantScience Policy InterfaceSurveillanceThe H1N1 PandemicVaccinesEarly Career ScientistsZoonoses Medium - Any -AgendaArticleFAQIn the mediaNewsPartner OrganisationsPhotoalbumPodcastsReportsScientific PapersStandpointsVideoInfographicPolicy & Recommendations NCD - risk group - Any -Chronic lung diseaseInfluenza Diabetes CommunityHeart diseaseKidney diseasesLiver disordersDiabetes and other metabolic disordersObesityImmunocomprimisedAsthmaSocio-economics risk groupsRacial and ethnic minority groupsOlder adultsChildrenPregnant womenHealth Care WorkersLow and Middle Income CountriesNon Communicable Diseases Network - Any -Influenza Diabetes CommunityEarly Career ScientistsCoallition PartnersOther Risk Group Communities Sort by Authored onTitle Order AscDesc Displaying 97 - 98 of 98 article(s). 1 Filter active Vaccines Topic Animal Influenza (21) Avian Influenza (7) H5N1 (18) Viral Times (14) Antibodies (4) Antivirals (8) Antivirals and monoclonal antibodies (11) Communication (41) COVID-19 (129) COVID-19 Pandemic (72) Diabetes (18) Diagnostics (5) Epidemiology (9) HPAI (3) Immunology (40) Influenza (100) Influenza Diabetes Community (7) Long-Covid (19) Low and Middle Income Countries (8) mRNA (7) One Health (17) Pandemic preparedness (51) Pandemic threats (34) Pathogenesis (3) Policy (77) Prevention (56) Public Health Care (62) RSV (76) SARS-CoV-2 (75) SARS-CoV-2 variant (25) Science Policy Interface (28) Surveillance (22) The H1N1 Pandemic (7) Vaccines (98) Early Career Scientists (15) Zoonoses (22) Medium Agenda (5) Article (21) News (287) Partner Organisations (6) Podcasts (30) Reports (27) Scientific Papers (160) Standpoints (3) Video (65) Infographic (1) Policy & Recommendations (34) NCD / Risk groups Chronic lung disease (1) Influenza Diabetes Community (23) Heart disease (4) Diabetes and other metabolic disorders (20) Asthma (1) Socio-economics risk groups (2) Older adults (46) Children (51) Pregnant women (7) Health Care Workers (4) Low and Middle Income Countries (3) Non Communicable Diseases (1) Topic Animal Influenza (21) Avian Influenza (7) H5N1 (18) Viral Times (14) Antibodies (4) Antivirals (8) Antivirals and monoclonal antibodies (11) Communication (41) COVID-19 (129) COVID-19 Pandemic (72) Diabetes (18) Diagnostics (5) Epidemiology (9) HPAI (3) Immunology (40) Influenza (100) Influenza Diabetes Community (7) Long-Covid (19) Low and Middle Income Countries (8) mRNA (7) One Health (17) Pandemic preparedness (51) Pandemic threats (34) Pathogenesis (3) Policy (77) Prevention (56) Public Health Care (62) RSV (76) SARS-CoV-2 (75) SARS-CoV-2 variant (25) Science Policy Interface (28) Surveillance (22) The H1N1 Pandemic (7) Vaccines (98) Early Career Scientists (15) Zoonoses (22) Medium Agenda (5) Article (21) News (287) Partner Organisations (6) Podcasts (30) Reports (27) Scientific Papers (160) Standpoints (3) Video (65) Infographic (1) Policy & Recommendations (34) NCD / Risk groups Chronic lung disease (1) Influenza Diabetes Community (23) Heart disease (4) Diabetes and other metabolic disorders (20) Asthma (1) Socio-economics risk groups (2) Older adults (46) Children (51) Pregnant women (7) Health Care Workers (4) Low and Middle Income Countries (3) Non Communicable Diseases (1)
Welcome to ESWI's Education Hub. Use the different filters or search button to find your preferred content.
Video | ESWI webinar series 2021 Vaccination in a COVID-19 era First webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Sylvie ... Video Partner Organisations | 7th Influenza Conference 2020 Should we introduce national live vaccination programmes for children? ESPID/ESWI joint symposium supported by AZ Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Current page 9 Search Search Keywords Title Topic - Any -Animal InfluenzaAvian InfluenzaH5N1Viral TimesAntibodiesAntivirals Antivirals and monoclonal antibodiesCommunicationCOVID-19COVID-19 PandemicDiabetesDiagnosticsEpidemiologyHPAIImmunologyInfluenzaInfluenza Diabetes CommunityLong-CovidLow and Middle Income CountriesmRNAOne HealthPandemic preparednessPandemic threatsPathogenesisPolicyPreventionPublic Health CareRSVSARS-CoV-2SARS-CoV-2 variantScience Policy InterfaceSurveillanceThe H1N1 PandemicVaccinesEarly Career ScientistsZoonoses Medium - Any -AgendaArticleFAQIn the mediaNewsPartner OrganisationsPhotoalbumPodcastsReportsScientific PapersStandpointsVideoInfographicPolicy & Recommendations NCD - risk group - Any -Chronic lung diseaseInfluenza Diabetes CommunityHeart diseaseKidney diseasesLiver disordersDiabetes and other metabolic disordersObesityImmunocomprimisedAsthmaSocio-economics risk groupsRacial and ethnic minority groupsOlder adultsChildrenPregnant womenHealth Care WorkersLow and Middle Income CountriesNon Communicable Diseases Network - Any -Influenza Diabetes CommunityEarly Career ScientistsCoallition PartnersOther Risk Group Communities Sort by Authored onTitle Order AscDesc Displaying 97 - 98 of 98 article(s). 1 Filter active Vaccines Topic Animal Influenza (21) Avian Influenza (7) H5N1 (18) Viral Times (14) Antibodies (4) Antivirals (8) Antivirals and monoclonal antibodies (11) Communication (41) COVID-19 (129) COVID-19 Pandemic (72) Diabetes (18) Diagnostics (5) Epidemiology (9) HPAI (3) Immunology (40) Influenza (100) Influenza Diabetes Community (7) Long-Covid (19) Low and Middle Income Countries (8) mRNA (7) One Health (17) Pandemic preparedness (51) Pandemic threats (34) Pathogenesis (3) Policy (77) Prevention (56) Public Health Care (62) RSV (76) SARS-CoV-2 (75) SARS-CoV-2 variant (25) Science Policy Interface (28) Surveillance (22) The H1N1 Pandemic (7) Vaccines (98) Early Career Scientists (15) Zoonoses (22) Medium Agenda (5) Article (21) News (287) Partner Organisations (6) Podcasts (30) Reports (27) Scientific Papers (160) Standpoints (3) Video (65) Infographic (1) Policy & Recommendations (34) NCD / Risk groups Chronic lung disease (1) Influenza Diabetes Community (23) Heart disease (4) Diabetes and other metabolic disorders (20) Asthma (1) Socio-economics risk groups (2) Older adults (46) Children (51) Pregnant women (7) Health Care Workers (4) Low and Middle Income Countries (3) Non Communicable Diseases (1) Topic Animal Influenza (21) Avian Influenza (7) H5N1 (18) Viral Times (14) Antibodies (4) Antivirals (8) Antivirals and monoclonal antibodies (11) Communication (41) COVID-19 (129) COVID-19 Pandemic (72) Diabetes (18) Diagnostics (5) Epidemiology (9) HPAI (3) Immunology (40) Influenza (100) Influenza Diabetes Community (7) Long-Covid (19) Low and Middle Income Countries (8) mRNA (7) One Health (17) Pandemic preparedness (51) Pandemic threats (34) Pathogenesis (3) Policy (77) Prevention (56) Public Health Care (62) RSV (76) SARS-CoV-2 (75) SARS-CoV-2 variant (25) Science Policy Interface (28) Surveillance (22) The H1N1 Pandemic (7) Vaccines (98) Early Career Scientists (15) Zoonoses (22) Medium Agenda (5) Article (21) News (287) Partner Organisations (6) Podcasts (30) Reports (27) Scientific Papers (160) Standpoints (3) Video (65) Infographic (1) Policy & Recommendations (34) NCD / Risk groups Chronic lung disease (1) Influenza Diabetes Community (23) Heart disease (4) Diabetes and other metabolic disorders (20) Asthma (1) Socio-economics risk groups (2) Older adults (46) Children (51) Pregnant women (7) Health Care Workers (4) Low and Middle Income Countries (3) Non Communicable Diseases (1)
1 Filter active Vaccines Topic Animal Influenza (21) Avian Influenza (7) H5N1 (18) Viral Times (14) Antibodies (4) Antivirals (8) Antivirals and monoclonal antibodies (11) Communication (41) COVID-19 (129) COVID-19 Pandemic (72) Diabetes (18) Diagnostics (5) Epidemiology (9) HPAI (3) Immunology (40) Influenza (100) Influenza Diabetes Community (7) Long-Covid (19) Low and Middle Income Countries (8) mRNA (7) One Health (17) Pandemic preparedness (51) Pandemic threats (34) Pathogenesis (3) Policy (77) Prevention (56) Public Health Care (62) RSV (76) SARS-CoV-2 (75) SARS-CoV-2 variant (25) Science Policy Interface (28) Surveillance (22) The H1N1 Pandemic (7) Vaccines (98) Early Career Scientists (15) Zoonoses (22) Medium Agenda (5) Article (21) News (287) Partner Organisations (6) Podcasts (30) Reports (27) Scientific Papers (160) Standpoints (3) Video (65) Infographic (1) Policy & Recommendations (34) NCD / Risk groups Chronic lung disease (1) Influenza Diabetes Community (23) Heart disease (4) Diabetes and other metabolic disorders (20) Asthma (1) Socio-economics risk groups (2) Older adults (46) Children (51) Pregnant women (7) Health Care Workers (4) Low and Middle Income Countries (3) Non Communicable Diseases (1) Topic Animal Influenza (21) Avian Influenza (7) H5N1 (18) Viral Times (14) Antibodies (4) Antivirals (8) Antivirals and monoclonal antibodies (11) Communication (41) COVID-19 (129) COVID-19 Pandemic (72) Diabetes (18) Diagnostics (5) Epidemiology (9) HPAI (3) Immunology (40) Influenza (100) Influenza Diabetes Community (7) Long-Covid (19) Low and Middle Income Countries (8) mRNA (7) One Health (17) Pandemic preparedness (51) Pandemic threats (34) Pathogenesis (3) Policy (77) Prevention (56) Public Health Care (62) RSV (76) SARS-CoV-2 (75) SARS-CoV-2 variant (25) Science Policy Interface (28) Surveillance (22) The H1N1 Pandemic (7) Vaccines (98) Early Career Scientists (15) Zoonoses (22) Medium Agenda (5) Article (21) News (287) Partner Organisations (6) Podcasts (30) Reports (27) Scientific Papers (160) Standpoints (3) Video (65) Infographic (1) Policy & Recommendations (34) NCD / Risk groups Chronic lung disease (1) Influenza Diabetes Community (23) Heart disease (4) Diabetes and other metabolic disorders (20) Asthma (1) Socio-economics risk groups (2) Older adults (46) Children (51) Pregnant women (7) Health Care Workers (4) Low and Middle Income Countries (3) Non Communicable Diseases (1)